Abstract:Purpose In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers. Methods Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by two-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry. Expression of the differential protein cytokeratin 18 in the above two tissues as well as 4 NPC cell lines was determined by Western blotting. Immunohistochemistry was also performed to detect the expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated. siRNA and in vitro cell invasion assay were used to check the correlation between the expression of cytokeratin 18 and invasive ability of NPC. Results Thirty-six differential proteins between the NPC and NNET were identified. The expression level of cytokeratin 18 in the two types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines. Significant cytokeratin 18 down-regulation was observed in NPC versus NNET ( P = 0.000), whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis versus primary NPC ( P = 0.001). In addition, cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation ( P = 0.000), whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage ( P = 0.019), recurrence ( P = 0.000), and regional lymph node metastasis ( P = 0.001), and distant metastasis ( P = 0.000). And down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells. Furthermore, survival curves showed that patients with cytokeratin 18 up-regulation had a poor prognosis ( P = 0.000). Univariate analysis (Cox’s proportional hazards model) showed that WHO histologic type ( P = 0.025), lymph node metastasis ( P = 0.007), distant metastasis ( P = 0.005), recurrence ( P = 0.000), and cytokeratin 18 ( P = 0.000) were significantly associated with the prognosis of NPC. Multivariate analysis confirmed that lymph node metastasis ( P = 0.012), distant metastasis ( P = 0.009), recurrence ( P = 0.006), and cytokeratin 18 ( P = 0.001) were independent prognostic indicators. Conclusions The data suggest that cytokeratin 18 is a potential biomarker for the differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.

Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma

Clinical Evaluation Of Circulating Tumor Cells In Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study.

Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients

Detection of circulating tumor cells in peripheral blood of patients with nasopharyngeal carcinoma and evaluate its prognostic value

Epithelial Circulating Tumor Cells with a Heterogeneous Phenotype Are Associated with Metastasis in NSCLC

The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study.

Circulating Tumor Cells with Karyotyping As a Novel Biomarker for Diagnosis and Treatment of Nasopharyngeal Carcinoma

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers

Detection and clinical significance of circulating tumor cells in peripheral blood of nasopharyngeal cancer patients with modified immunomagnetic enrichment and fluorescent immunocytochemistry

Epithelial-mesenchymal transition classification of circulating tumor cells in lung and colon cancer patients: potential role in clinical practice.

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma

Prognostic Implications of a Molecular Classifier Derived from Whole‐exome Sequencing in Nasopharyngeal Carcinoma

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer

Peripheral NK-cell immunophenotypes predict progression in nasopharyngeal carcinoma patients.

Development of a Risk Classification System Combining TN-categories and Circulating EBV DNA for Non-Metastatic NPC in 10,149 Endemic Cases.

Epithelial‑mesenchymal Transition Phenotype of Circulating Tumor Cells is Associated with Distant Metastasis in Patients with NSCLC.

Circulating Tumor DNA Profiling Approach Based on in Silico Background Elimination Guides Chemotherapy in Nasopharyngeal Carcinoma.

Typing of circulating tumor cells for non-small cell lung cancer

Longitudinal Circulating Epstein–Barr Virus DNA Response to Induction Chemotherapy and Chemo-Radiotherapy to Identify Biological Phenotypes in EBV-associated Nasopharynx of Head and Neck Cancer.

Proteomic Analysis to Identify Cytokeratin 18 As a Novel Biomarker of Nasopharyngeal Carcinoma